Voltar aos Detalhes do Artigo
CORTICOSTEROID THERAPY ASSOCIATED WITH COVID-19: AN ALLY OR A RISK FACTOR FOR THE ESTABLISHMENT OF SECONDARY FUNGAL CO-INFECTIONS?
Baixar
Baixar PDF